Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters
Joint workshop of AAPS and the International Transporter Consortium covers the current state of drug transporter knowledge and looks into the future
EXTON, Pa., April 20, 2015 /PRNewswire/ -- The preclinical contract research organization Absorption Systems, a global leader in pharmacokinetic testing of drugs and safety testing of medical devices, announces that its Chief Scientist, Ismael Hidalgo, will present at this week's workshop "Drug Transporters in ADME: From the Bench to the Bedside" in Baltimore, MD. The title of Dr. Hidalgo's talk is "Modern Tools for the Study of Membrane Transporters," part of a session entitled "Transporter Tools of the Future."
The workshop, organized jointly by AAPS (the American Association of Pharmaceutical Scientists) and ITC (the International Transporter Consortium), features the world's leading researchers on drug transporters, from academia, the drug industry, and drug regulatory agencies. The program, which includes speakers from North America, Europe, and Asia, covers three full days (April 20-22).
Dr. Hidalgo commented that "This workshop is a great opportunity, both to let people know what we've done and to discuss the latest research in this fast-moving field with other experts. We have all learned a lot in the past decade, but there's a lot more to learn. And it's important, because what we know about drug transporters contributes directly to the development of safer and more effective drugs."
About Absorption Systems
Absorption Systems, founded in 1996, assists pharmaceutical, biotechnology and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) barriers in the development of drugs, biologics and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. The CellPort Technologies® platform, a suite of human cell-based test systems for drug transporter characterization, exemplifies Absorption Systems' commitment to innovation and is soon to be an industry standard for in vitro drug interaction assessment. Absorption Systems, with facilities near Philadelphia, PA, in San Diego, CA, and in Panama, serves customers throughout the world. For information on the company's comprehensive contract services and applied research programs, please visit www.absorption.com.
Chris Bode
Absorption Systems
1-610-280-1451
[email protected]
www.absorption.com
SOURCE Absorption Systems
Share this article